Cargando…

The Subjective Experience of Using Medications: What We Know and the Paths Forward

Medications can cause bodily changes, where the associated benefits and risks are carefully assessed based on the changes experienced in the phenomenal body. For this reason, the phenomenology of Merleau-Ponty is an important theoretical framework for the study of experience related to the daily use...

Descripción completa

Detalles Bibliográficos
Autores principales: de Almeida Nascimento, Yone, Ramalho-de-Oliveira, Djenane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006003/
https://www.ncbi.nlm.nih.gov/pubmed/33801298
http://dx.doi.org/10.3390/pharmacy9010050
_version_ 1783672227179266048
author de Almeida Nascimento, Yone
Ramalho-de-Oliveira, Djenane
author_facet de Almeida Nascimento, Yone
Ramalho-de-Oliveira, Djenane
author_sort de Almeida Nascimento, Yone
collection PubMed
description Medications can cause bodily changes, where the associated benefits and risks are carefully assessed based on the changes experienced in the phenomenal body. For this reason, the phenomenology of Merleau-Ponty is an important theoretical framework for the study of experience related to the daily use of medications. The aim of this study was to discuss the contribution of a recently developed framework of the general ways people can experience the daily use of medications—resolution, adversity, ambiguity, and irrelevance—and present reflections about the little-understood aspects of this experience. However, some issues raised throughout this article remain open and invite us to further exploration, such as (1) the coexistence of multiple ways of experiencing the use of medications, by the same individual, in a given historical time; (2) the cyclical structure of this experience; (3) the impact of habit and routine on the ways of experiencing the daily use of medications; and (4) the contribution of the concept of existential feelings to this experience and its impact on patients’ decision-making. Therefore, the experience with the daily use of medications is a complex and multifaceted phenomenon that directs the decision-making process of patients, impacting health outcomes.
format Online
Article
Text
id pubmed-8006003
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80060032021-03-30 The Subjective Experience of Using Medications: What We Know and the Paths Forward de Almeida Nascimento, Yone Ramalho-de-Oliveira, Djenane Pharmacy (Basel) Commentary Medications can cause bodily changes, where the associated benefits and risks are carefully assessed based on the changes experienced in the phenomenal body. For this reason, the phenomenology of Merleau-Ponty is an important theoretical framework for the study of experience related to the daily use of medications. The aim of this study was to discuss the contribution of a recently developed framework of the general ways people can experience the daily use of medications—resolution, adversity, ambiguity, and irrelevance—and present reflections about the little-understood aspects of this experience. However, some issues raised throughout this article remain open and invite us to further exploration, such as (1) the coexistence of multiple ways of experiencing the use of medications, by the same individual, in a given historical time; (2) the cyclical structure of this experience; (3) the impact of habit and routine on the ways of experiencing the daily use of medications; and (4) the contribution of the concept of existential feelings to this experience and its impact on patients’ decision-making. Therefore, the experience with the daily use of medications is a complex and multifaceted phenomenon that directs the decision-making process of patients, impacting health outcomes. MDPI 2021-03-02 /pmc/articles/PMC8006003/ /pubmed/33801298 http://dx.doi.org/10.3390/pharmacy9010050 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Commentary
de Almeida Nascimento, Yone
Ramalho-de-Oliveira, Djenane
The Subjective Experience of Using Medications: What We Know and the Paths Forward
title The Subjective Experience of Using Medications: What We Know and the Paths Forward
title_full The Subjective Experience of Using Medications: What We Know and the Paths Forward
title_fullStr The Subjective Experience of Using Medications: What We Know and the Paths Forward
title_full_unstemmed The Subjective Experience of Using Medications: What We Know and the Paths Forward
title_short The Subjective Experience of Using Medications: What We Know and the Paths Forward
title_sort subjective experience of using medications: what we know and the paths forward
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006003/
https://www.ncbi.nlm.nih.gov/pubmed/33801298
http://dx.doi.org/10.3390/pharmacy9010050
work_keys_str_mv AT dealmeidanascimentoyone thesubjectiveexperienceofusingmedicationswhatweknowandthepathsforward
AT ramalhodeoliveiradjenane thesubjectiveexperienceofusingmedicationswhatweknowandthepathsforward
AT dealmeidanascimentoyone subjectiveexperienceofusingmedicationswhatweknowandthepathsforward
AT ramalhodeoliveiradjenane subjectiveexperienceofusingmedicationswhatweknowandthepathsforward